Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileJerome Lewis Avorn, M.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressDivision of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital, Suite 3030
1620 Tremont St
Boston MA 02120
Phone617/278-0930
Fax617/232-8602
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
Qualitative Analysis of the March-in Rights Clause of the Bayh-Dole Act
Summer, 04/01/13 - 10/31/13
The Effects of Direct to Consumer Advertising on Prescription Drug Sales: A Comparative International Analysis
Summer, 06/04/12 - 08/31/12
Trends in Direct-to-Consumer Advertising of Prescription Contraceptives
Full Time/Year Long, 06/01/15 - 05/01/16
The Effect of Fraud Investigation on Trends in Off-Label Neurontin Use: A Segmented Time Series Analysis
Summer, 02/09/10 - 09/21/10
Studies on the Cost Effectiveness of Pharmacologic Interventions to Prevent Stroke
Full Time/Year Long, 07/01/98 - 06/30/99

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
U01HL115662     (CHOUDHRY, NITEESH K)Sep 17, 2013 - Mar 31, 2019
NIH/NHLBI
BEST-CLI Trial - Cost-Effectiveness of Treatments for Critical Limb Ischemia
Role: Co-Principal Investigator

R03AG018395     (AVORN, JEROME L)Sep 30, 2000 - Jan 31, 2002
NIH/NIA
DRUGS AND AGING--DEMOGRAPHIC, CLINICAL, AND COST DATA
Role: Principal Investigator

R01HS009398     (AVORN, JEROME L)Sep 30, 1996 - Sep 29, 1999
AHRQ
NEPHROLOGIST CARE AND OUTCOMES IN RENAL INSUFFICIENCY
Role: Principal Investigator

R01DA010014     (AVORN, JEROME L)Sep 10, 1996 - Aug 31, 1999
NIH/NIDA
RISKY GERIATRIC BENZODIAZEPINE USE--PREDICTORS &TRENDS
Role: Principal Investigator

R01AG009634     (AVORN, JEROME L)Feb 1, 1991 - Jan 31, 1993
NIH/NIA
DRUG-INDUCED PARKINSONIAN SYMPTOMS IN THE ELDERLY
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Avorn J. In Opposition to Liberty: We Need a "Sovereign" to Govern Drug Claims. Ann Intern Med. 2015 Aug 04; 163(3):229-30. PMID: 26121615.
    View in: PubMed
  2. Avorn J, Kesselheim AS. The 21st Century Cures Act--Will It Take Us Back in Time? N Engl J Med. 2015 Jun 25; 372(26):2473-5. PMID: 26039522.
    View in: PubMed
  3. Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J. Methodological approaches to evaluate the impact of FDA drug safety communications. Drug Saf. 2015 Jun; 38(6):565-75. PMID: 25968811.
    View in: PubMed
  4. Avorn J. The $2.6 billion pill--methodologic and policy considerations. N Engl J Med. 2015 May 14; 372(20):1877-9. PMID: 25970049.
    View in: PubMed
  5. Sarpatwari A, Avorn J, Kesselheim AS. Progress and Hurdles for Follow-on Biologics. N Engl J Med. 2015 Jun 18; 372(25):2380-2. PMID: 25946143.
    View in: PubMed
  6. Ito K, Avorn J, Shrank WH, Toscano M, Spettel C, Brennan T, Choudhry NK. Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):252-9. PMID: 25944633.
    View in: PubMed
  7. Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. Paying physicians to prescribe generic drugs and follow-on biologics in the United States. PLoS Med. 2015 Mar; 12(3):e1001802. PMID: 25781468; PMCID: PMC4363899.
  8. Bateman BT, Hernandez-Diaz S, Fischer MA, Seely EW, Ecker JL, Franklin JM, Desai RJ, Allen-Coleman C, Mogun H, Avorn J, Huybrechts KF. Statins and congenital malformations: cohort study. BMJ. 2015 Mar 17; 350:h1035. PMID: 25784688; PMCID: PMC4362473.
  9. Najafzadeh M, Andersson K, Shrank WH, Krumme AA, Matlin OS, Brennan T, Avorn J, Choudhry NK. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med. 2015 Mar 17; 162(6):407-19. PMID: 25775313.
    View in: PubMed
  10. Kesselheim AS, Connolly J, Rogers J, Avorn J. Mandatory disclaimers on dietary supplements do not reliably communicate the intended issues. Health Aff (Millwood). 2015 Mar; 34(3):438-46. PMID: 25732494.
    View in: PubMed
  11. Avorn J. Rethinking the use of physicians as hired expert lecturers--response. Ann Intern Med. 2015 Feb 17; 162(4):321-2. PMID: 25686178.
    View in: PubMed
  12. Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. 2015 May; 128(5):519-26.e1. PMID: 25660252; PMCID: PMC4414898.
  13. Kesselheim AS, Tan YT, Avorn J. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs. Health Aff (Millwood). 2015 Feb; 34(2):286-93. PMID: 25646109.
    View in: PubMed
  14. Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med. 2015 Jan 15; 372(3):279-86. PMID: 25587952.
    View in: PubMed
  15. Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia. Clin Pharmacol Ther. 2015 Feb; 97(2):186-93. PMID: 25670524.
    View in: PubMed
  16. Kesselheim AS, Choudhry NK, Avorn J. Burden of changes in generic pill appearance. Ann Intern Med. 2014 Dec 02; 161(11):840. PMID: 25437416.
    View in: PubMed
  17. Berkowitz SA, Krumme AA, Avorn J, Brennan T, Matlin OS, Spettell CM, Pezalla EJ, Brill G, Shrank WH, Choudhry NK. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study. JAMA Intern Med. 2014 Dec; 174(12):1955-62. PMID: 25347323.
    View in: PubMed
  18. Najafzadeh M, Gagne JJ, Choudhry NK, Polinski JM, Avorn J, Schneeweiss SS. Patients' preferences in anticoagulant therapy: discrete choice experiment. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):912-9. PMID: 25387782.
    View in: PubMed
  19. Yeh JS, Austad KE, Franklin JM, Chimonas S, Campbell EG, Avorn J, Kesselheim AS. Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study. PLoS Med. 2014 Oct; 11(10):e1001743. PMID: 25314155; PMCID: PMC4196737.
  20. Kesselheim AS, Tan YT, Darrow JJ, Avorn J. Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs. Health Aff (Millwood). 2014 Oct; 33(10):1770-8. PMID: 25288421.
    View in: PubMed
  21. Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA. 2014 Sep 24; 312(12):1237-47. PMID: 25247520; PMCID: PMC4209732.
  22. Huybrechts KF, Hernández-Díaz S, Avorn J. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014 Sep 18; 371(12):1168-9. PMID: 25229932.
    View in: PubMed
  23. Gagne JJ, Choudhry NK, Kesselheim AS, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med. 2014 Sep 16; 161(6):400-7. PMID: 25222387.
    View in: PubMed
  24. Avorn J. Rethinking the use of physicians as hired expert lecturers. Ann Intern Med. 2014 Sep 02; 161(5):363-4. PMID: 25178570.
    View in: PubMed
  25. Austad KE, Avorn J, Franklin JM, Campbell EG, Kesselheim AS. Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey. JAMA Intern Med. 2014 Aug; 174(8):1283-90. PMID: 24911123.
    View in: PubMed
  26. Kesselheim AS, Bykov K, Avorn J, Tong A, Doherty M, Choudhry NK. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med. 2014 Jul 15; 161(2):96-103. PMID: 25023248.
    View in: PubMed
  27. Darrow JJ, Avorn J, Kesselheim AS. New FDA breakthrough-drug category--implications for patients. N Engl J Med. 2014 Jul 03; 371(1):89-90. PMID: 24988576.
    View in: PubMed
  28. Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014 Jun 19; 370(25):2397-407. PMID: 24941178; PMCID: PMC4062924.
  29. Larkin I, Ang D, Avorn J, Kesselheim AS. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children. Health Aff (Millwood). 2014 Jun; 33(6):1014-23. PMID: 24889951.
    View in: PubMed
  30. Desai NR, Krumme AA, Schneeweiss S, Shrank WH, Brill G, Pezalla EJ, Spettell CM, Brennan TA, Matlin OS, Avorn J, Choudhry NK. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications. Am J Med. 2014 Nov; 127(11):1075-82.e1. PMID: 24859719.
    View in: PubMed
  31. Hwang TJ, Avorn J, Kesselheim AS. Life cycle of medical product rules issued by the US Food and Drug Administration. J Health Polit Policy Law. 2014 Aug; 39(4):751-80. PMID: 24842974.
    View in: PubMed
  32. Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA. Unintended consequences of a Medicaid prescription copayment policy. Med Care. 2014 May; 52(5):422-7. PMID: 24686394.
    View in: PubMed
  33. Franklin JM, Choudhry NK, Uscher-Pines L, Brill G, Matlin OS, Fischer MA, Schneeweiss S, Avorn J, Brennan TA, Shrank WH. Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic. Am J Public Health. 2014 Jun; 104(6):1052-8. PMID: 24825206; PMCID: PMC4062027.
  34. Sarpatwari A, Avorn J, Kesselheim AS. Using a drug-safety tool to prevent competition. N Engl J Med. 2014 Apr 17; 370(16):1476-8. PMID: 24738666.
    View in: PubMed
  35. Darrow JJ, Avorn J, Kesselheim AS. New FDA breakthrough-drug category--implications for patients. N Engl J Med. 2014 Mar 27; 370(13):1252-8. PMID: 24670173.
    View in: PubMed
  36. Huybrechts KF, Sanghani RS, Avorn J, Urato AC. Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS One. 2014; 9(3):e92778. PMID: 24671232; PMCID: PMC3966829.
  37. Treasure CL, Avorn J, Kesselheim AS. What is the public's right to access medical discoveries based on federally funded research? JAMA. 2014 Mar 05; 311(9):907-8. PMID: 24595771.
    View in: PubMed
  38. Choudhry NK, Fischer MA, Smith BF, Brill G, Girdish C, Matlin OS, Brennan TA, Avorn J, Shrank WH. Five features of value-based insurance design plans were associated with higher rates of medication adherence. Health Aff (Millwood). 2014 Mar; 33(3):493-501. PMID: 24522551.
    View in: PubMed
  39. Kesselheim AS, Xu S, Avorn J. Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation. PLoS One. 2014; 9(2):e88664. PMID: 24533133; PMCID: PMC3922977.
  40. Hwang TJ, Avorn J, Carpenter D, Kesselheim AS. Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparency. Health Aff (Millwood). 2014 Feb; 33(2):309-15. PMID: 24493775.
    View in: PubMed
  41. Toh S, Avorn J, D'Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL. RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):109-10. PMID: 24395550.
    View in: PubMed
  42. Kesselheim AS, Avorn J. New and unproved medical devices. BMJ. 2013 Dec 19; 347:f7413. PMID: 24355541.
    View in: PubMed
  43. Canestaro WJ, Patrick AR, Avorn J, Ito K, Matlin OS, Brennan TA, Shrank WH, Choudhry NK. Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):724-31. PMID: 24221832.
    View in: PubMed
  44. Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, Toscano M, Levin R, Matlin OS, Antman EM, Shrank WH. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5. PMID: 24332142.
    View in: PubMed
  45. Patrick AR, Fischer MA, Choudhry NK, Shrank WH, Seeger JD, Liu J, Avorn J, Polinski JM. Trends in insulin initiation and treatment intensification among patients with type 2 diabetes. J Gen Intern Med. 2014 Feb; 29(2):320-7. PMID: 24101534; PMCID: PMC3912271.
  46. Austad KE, Avorn J, Franklin JM, Kesselheim AS. Physician trainees' interactions with the pharmaceutical industry. J Gen Intern Med. 2013 Oct; 28(10):1267. PMID: 23797922; PMCID: PMC3785663.
  47. Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ. 2013 Sep 17; 347:f5307. PMID: 24046285; PMCID: PMC3775704.
  48. Kesselheim AS, Green MD, Avorn J. Who is now responsible for discovering and warning about adverse effects of generic drugs? JAMA. 2013 Sep 11; 310(10):1023-4. PMID: 23922000.
    View in: PubMed
  49. Wang B, Avorn J, Kesselheim AS. Clinical and regulatory features of drugs not initially approved by the FDA. Clin Pharmacol Ther. 2013 Dec; 94(6):670-7. PMID: 23963252.
    View in: PubMed
  50. Avorn J. The promise of pharmacoepidemiology in helping clinicians assess drug risk. Circulation. 2013 Aug 13; 128(7):745-8. PMID: 23940388.
    View in: PubMed
  51. Toh S, Avorn J, D'Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf. 2013 Oct; 22(10):1036-45. PMID: 23922322.
    View in: PubMed
  52. Austad KE, Avorn J, Franklin JM, Kowal MK, Campbell EG, Kesselheim AS. Changing interactions between physician trainees and the pharmaceutical industry: a national survey. J Gen Intern Med. 2013 Aug; 28(8):1064-71. PMID: 23444007; PMCID: PMC3710396.
  53. Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013 Jul 30; 2(4):e000208. PMID: 23900213; PMCID: PMC3828795.
  54. Bateman BT, Huybrechts KF, Hernandez-Diaz S, Liu J, Ecker JL, Avorn J. Methylergonovine maleate and the risk of myocardial ischemia and infarction. Am J Obstet Gynecol. 2013 Nov; 209(5):459.e1-459.e13. PMID: 23850529; PMCID: PMC4103983.
  55. Kesselheim AS, Wang B, Avorn J. Defining "innovativeness" in drug development: a systematic review. Clin Pharmacol Ther. 2013 Sep; 94(3):336-48. PMID: 23722626.
    View in: PubMed
  56. Kesselheim AS, Avorn J. The most transformative drugs of the past 25 years: a survey of physicians. Nat Rev Drug Discov. 2013 06; 12(6):425-31. PMID: 23681007.
    View in: PubMed
  57. Kesselheim AS, Franklin JM, Avorn J, Duke JD. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs. BMJ Qual Saf. 2013 Sep; 22(9):727-34. PMID: 23620531.
    View in: PubMed
  58. Avorn J. Approval of a tuberculosis drug based on a paradoxical surrogate measure. JAMA. 2013 Apr 03; 309(13):1349-50. PMID: 23430122.
    View in: PubMed
  59. Kesselheim AS, Misono AS, Shrank WH, Greene JA, Doherty M, Avorn J, Choudhry NK. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med. 2013 Feb 11; 173(3):202-8. PMID: 23277164.
    View in: PubMed
  60. Kesselheim AS, Mello MM, Avorn J. FDA regulation of off-label drug promotion under attack. JAMA. 2013 Feb 06; 309(5):445-6. PMID: 23385267.
    View in: PubMed
  61. Huybrechts KF, Palmsten K, Mogun H, Kowal M, Avorn J, Setoguchi-Iwata S, Hernández-Díaz S. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013 May-Jun; 35(3):265-71. PMID: 23374897; PMCID: PMC4077674.
  62. Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim S, Rothman KJ, Liu J, Avorn J. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012 Nov 26; 12:180. PMID: 23181419; PMCID: PMC3533513.
  63. Kesselheim AS, Avorn J, Greene JA. Risk, responsibility, and generic drugs. N Engl J Med. 2012 11 01; 367(18):1679-81. PMID: 23113477; PMCID: PMC4036072.
  64. Xu S, Avorn J, Kesselheim AS. Origins of medical innovation: the case of coronary artery stents. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):743-9. PMID: 23093563.
    View in: PubMed
  65. Kesselheim AS, Avorn J. Drug labels: a flawed source of data for studying orphan drug approvals. Clin Pharmacol Ther. 2012 Dec; 92(6):694; author reply 695. PMID: 23073207.
    View in: PubMed
  66. Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol. 2012 Oct 30; 60(18):1817-24. PMID: 23040581.
    View in: PubMed
  67. Kesselheim AS, Avorn J. The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness research. Health Aff (Millwood). 2012 Oct; 31(10):2200-5. PMID: 23048097.
    View in: PubMed
  68. Fischer MA, Avorn J. Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings. Health Aff (Millwood). 2012 Oct; 31(10):2206-12. PMID: 23048098.
    View in: PubMed
  69. Ito K, Shrank WH, Avorn J, Patrick AR, Brennan TA, Antman EM, Choudhry NK. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res. 2012 Dec; 47(6):2097-117. PMID: 22998129; PMCID: PMC3523366.
  70. Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. N Engl J Med. 2012 Sep 20; 367(12):1119-27. PMID: 22992075; PMCID: PMC3538846.
  71. Huybrechts KF, Seeger JD, Rothman KJ, Glynn RJ, Avorn J, Schneeweiss S. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e61-4. PMID: 22991351; PMCID: PMC3519359.
  72. Kesselheim AS, Wang B, Studdert DM, Avorn J. Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures. PLoS Med. 2012; 9(8):e1001280. PMID: 22899894; PMCID: PMC3413710.
  73. Avorn J. Two centuries of assessing drug risks. N Engl J Med. 2012 Jul 19; 367(3):193-7. PMID: 22808954.
    View in: PubMed
  74. Madigan D, Sigelman DW, Mayer JW, Furberg CD, Avorn J. Under-reporting of cardiovascular events in the rofecoxib Alzheimer disease studies. Am Heart J. 2012 Aug; 164(2):186-93. PMID: 22877803.
    View in: PubMed
  75. Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2012 Jul 01; 5(4):480-6. PMID: 22787066; PMCID: PMC3471365.
  76. Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int. 2013 Jan; 24(1):237-44. PMID: 22707065.
    View in: PubMed
  77. Shrank WH, Choudhry NK, Tong A, Myers J, Fischer MA, Swanton K, Slezak J, Brennan TA, Liberman JN, Moffit S, Avorn J, Carpenter D. Warnings without guidance: patient responses to an FDA warning about ezetimibe. Med Care. 2012 Jun; 50(6):479-84. PMID: 22581012.
    View in: PubMed
  78. Wahl PM, Gagne JJ, Wasser TE, Eisenberg DF, Rodgers JK, Daniel GW, Wilson M, Schneeweiss S, Rassen JA, Patrick AR, Avorn J, Bohn RL. Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples. Drug Saf. 2012 May 01; 35(5):407-16. PMID: 22489640.
    View in: PubMed
  79. Singh JP, Kulik A, Levin R, Ellinor PT, Ruskin J, Avorn J, Choudhry NK. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Europace. 2012 Sep; 14(9):1287-93. PMID: 22539600.
    View in: PubMed
  80. Lunt M, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. Propensity score calibration in the absence of surrogacy. Am J Epidemiol. 2012 Jun 15; 175(12):1294-302. PMID: 22688682; PMCID: PMC3491974.
  81. Desai NR, Shrank WH, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Choudhry NK. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med. 2012 Mar; 125(3):302.e1-7. PMID: 22340932; PMCID: PMC4347833.
  82. Solomon DH, Iversen MD, Avorn J, Gleeson T, Brookhart MA, Patrick AR, Rekedal L, Shrank WH, Lii J, Losina E, Katz JN. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med. 2012 Mar 26; 172(6):477-83. PMID: 22371876; PMCID: PMC3905804.
  83. Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012 Feb 23; 344:e977. PMID: 22362541; PMCID: PMC3285717.
  84. Kesselheim AS, Myers JA, Solomon DH, Winkelmayer WC, Levin R, Avorn J. The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894. PMID: 22363762; PMCID: PMC3283698.
  85. Huybrechts KF, Schneeweiss S, Gerhard T, Olfson M, Avorn J, Levin R, Lucas JA, Crystal S. Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc. 2012 Mar; 60(3):420-9. PMID: 22329464; PMCID: PMC3302976.
  86. Gagne JJ, Avorn J, Shrank WH, Schneeweiss S. Comment: generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies. Ann Pharmacother. 2012 Feb; 46(2):303-4; author reply 304. PMID: 22274141.
    View in: PubMed
  87. Avorn J. Learning about the safety of drugs--a half-century of evolution. N Engl J Med. 2011 Dec 08; 365(23):2151-3. PMID: 22150034.
    View in: PubMed
  88. Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Health Aff (Millwood). 2011 Dec; 30(12):2318-27. PMID: 22147859.
    View in: PubMed
  89. Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 01; 365(22):2088-97. PMID: 22080794.
    View in: PubMed
  90. Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, Liberman JN, Brennan TA, Shrank WH. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011 Nov; 124(11):1081.e9-22. PMID: 22017787.
    View in: PubMed
  91. Avorn J, Kesselheim AS. The NIH translational research center might trade public risk for private reward. Nat Med. 2011 Oct 11; 17(10):1176. PMID: 21988983.
    View in: PubMed
  92. Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK. Conflict of interest in oncology publications: a survey of disclosure policies and statements. Cancer. 2012 Jan 01; 118(1):188-95. PMID: 21717432.
    View in: PubMed
  93. Kesselheim AS, Myers JA, Avorn J. Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. JAMA. 2011 Jun 08; 305(22):2320-6. PMID: 21642684.
    View in: PubMed
  94. Austad KE, Avorn J, Kesselheim AS. Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review. PLoS Med. 2011 May; 8(5):e1001037. PMID: 21629685; PMCID: PMC3101205.
  95. Avorn J. The relative cost-effectiveness of anticoagulants: obvious, except for the cost and the effectiveness. Circulation. 2011 Jun 07; 123(22):2519-21. PMID: 21606400.
    View in: PubMed
  96. Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Shrank WH. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011 May 09; 171(9):814-22. PMID: 21555659.
    View in: PubMed
  97. Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, Cadarette SM, Mogun H, Brookhart MA. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011 Jun; 14(4):513-20. PMID: 21669377.
    View in: PubMed
  98. Avorn J, Kesselheim A. A hemorrhage of off-label use. Ann Intern Med. 2011 Apr 19; 154(8):566-7. PMID: 21502655.
    View in: PubMed
  99. Shrank WH, Liberman JN, Fischer MA, Avorn J, Kilabuk E, Chang A, Kesselheim AS, Brennan TA, Choudhry NK. The consequences of requesting "dispense as written". Am J Med. 2011 Apr; 124(4):309-17. PMID: 21435421.
    View in: PubMed
  100. Avorn J. Teaching clinicians about drugs--50 years later, whose job is it? N Engl J Med. 2011 Mar 31; 364(13):1185-7. PMID: 21449781.
    View in: PubMed
  101. Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011 Jun; 20(6):551-9. PMID: 21394812; PMCID: PMC3123427.
  102. Brookhart MA, Bradbury BD, Avorn J, Schneeweiss S, Winkelmayer WC. The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol. 2011 Apr 01; 173(7):768-77. PMID: 21345929; PMCID: PMC3105277.
  103. Parikh S, Brookhart MA, Stedman M, Avorn J, Mogun H, Solomon DH. Correlations of nursing home characteristics with prescription of osteoporosis medications. Bone. 2011 May 01; 48(5):1164-8. PMID: 21320653; PMCID: PMC3096758.
  104. Choudhry NK, Patrick AR, Glynn RJ, Avorn J. The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. J Am Coll Cardiol. 2011 Feb 15; 57(7):784-91. PMID: 21310313.
    View in: PubMed
  105. Schneeweiss S, Avorn J. Postmarketing studies of drug safety. BMJ. 2011 Feb 08; 342:d342. PMID: 21303880.
    View in: PubMed
  106. Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011 Jul; 64(7):749-59. PMID: 21208778; PMCID: PMC3100405.
  107. Shrank WH, Choudhry NK, Fischer MA, Avorn J, Powell M, Schneeweiss S, Liberman JN, Dollear T, Brennan TA, Brookhart MA. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010 Nov 16; 153(10):633-40. PMID: 21079218.
    View in: PubMed
  108. Avorn J. Regulation of devices. BMJ. 2010 Nov 02; 341:c5730. PMID: 21045051.
    View in: PubMed
  109. Choudhry NK, Fischer MA, Avorn J, Schneeweiss S, Solomon DH, Berman C, Jan S, Liu J, Lii J, Brookhart MA, Mahoney JJ, Shrank WH. At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood). 2010 Nov; 29(11):1995-2001. PMID: 21041738.
    View in: PubMed
  110. Avorn J. Medication use in older patients: better policy could encourage better practice. JAMA. 2010 Oct 13; 304(14):1606-7. PMID: 20940388.
    View in: PubMed
  111. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1248-55. PMID: 20931664; PMCID: PMC4018736.
  112. Chokshi DA, Avorn J, Kesselheim AS. Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature. Health Aff (Millwood). 2010 Oct; 29(10):1842-8. PMID: 20921484.
    View in: PubMed
  113. Avorn J, Fischer M. 'Bench to behavior': translating comparative effectiveness research into improved clinical practice. Health Aff (Millwood). 2010 Oct; 29(10):1891-900. PMID: 20921491.
    View in: PubMed
  114. Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol. 2010 Oct 01; 172(7):843-54. PMID: 20716704; PMCID: PMC3025652.
  115. Rassen JA, Avorn J, Schneeweiss S. Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases. Pharmacoepidemiol Drug Saf. 2010 Aug; 19(8):848-57. PMID: 20162632; PMCID: PMC2914827.
  116. Gagne JJ, Avorn J, Shrank WH, Schneeweiss S. Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther. 2010 Sep; 88(3):347-53. PMID: 20631693; PMCID: PMC2996138.
  117. Avorn J, Choudhry NK. Funding for medical education: maintaining a healthy separation from industry. Circulation. 2010 May 25; 121(20):2228-34. PMID: 20497986.
    View in: PubMed
  118. Avorn J. Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use". Arch Intern Med. 2010 May 24; 170(10):858-60. PMID: 20498412.
    View in: PubMed
  119. Kulik A, Singh JP, Levin R, Avorn J, Choudhry NK. Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Am J Cardiol. 2010 Jun 15; 105(12):1655-60. PMID: 20538110.
    View in: PubMed
  120. Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010 Apr 14; 303(14):1401-9. PMID: 20388896.
    View in: PubMed
  121. Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010 Mar 26; 70(5):605-21. PMID: 20329806; PMCID: PMC3056509.
  122. Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64. PMID: 20197532.
    View in: PubMed
  123. Wang PS, Patrick AR, Dormuth C, Maclure M, Avorn J, Canning CF, Schneeweiss S. Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants. J Ment Health Policy Econ. 2010 Mar; 13(1):37-44. PMID: 20571181; PMCID: PMC2892389.
  124. Setoguchi S, Higgins JM, Mogun H, Mootha VK, Avorn J. Propranolol and the risk of hospitalized myopathy: translating chemical genomics findings into population-level hypotheses. Am Heart J. 2010 Mar; 159(3):428-33. PMID: 20211305.
    View in: PubMed
  125. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, Solomon D, Brookhart MA, Choudhry NK. Patient, physician, and payment predictors of statin adherence. Med Care. 2010 Mar; 48(3):196-202. PMID: 19890219.
    View in: PubMed
  126. Schneeweiss S, Glynn RJ, Avorn J, Mamdani M, Mogun H, Solomon DH. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1134-42. PMID: 19844943.
    View in: PubMed
  127. Rassen JA, Choudhry NK, Avorn J, Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009 Dec 08; 120(23):2322-9. PMID: 19933932; PMCID: PMC2818789.
  128. Engelberg AB, Kesselheim AS, Avorn J. Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med. 2009 Nov 12; 361(20):1917-9. PMID: 19828525.
    View in: PubMed
  129. Shrank WH, Patrick A, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, Brookhart MA, Schneeweiss S, Solomon DH, Wolf MS, Avorn J, Choudhry NK. An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care. 2009 Sep; 47(9):1031-5. PMID: 19648829; PMCID: PMC2873616.
  130. Avorn J, Schneeweiss S. Managing drug-risk information--what to do with all those new numbers. N Engl J Med. 2009 Aug 13; 361(7):647-9. PMID: 19635948.
    View in: PubMed
  131. Patrick AR, Avorn J, Choudhry NK. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2009 Sep; 2(5):429-36. PMID: 20031873.
    View in: PubMed
  132. Avorn J, Schneeweiss S. Imuunosuppressants, mortality, and risk of cancer. BMJ. 2009 Jul 03; 339:b1645. PMID: 19578084.
    View in: PubMed
  133. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009 Jul; 20(4):512-22. PMID: 19487948; PMCID: PMC3077219.
  134. Gleeson T, Iversen MD, Avorn J, Brookhart AM, Katz JN, Losina E, May F, Patrick AR, Shrank WH, Solomon DH. Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int. 2009 Dec; 20(12):2127-34. PMID: 19499273; PMCID: PMC3257053.
  135. Solomon DH, Gleeson T, Iversen M, Avorn J, Brookhart MA, Lii J, Losina E, May F, Patrick A, Shrank WH, Katz JN. A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteoporos Int. 2010 Jan; 21(1):137-44. PMID: 19436935; PMCID: PMC2922963.
  136. Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med. 2009 May 07; 360(19):1927-9. PMID: 19420361.
    View in: PubMed
  137. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, Avorn J, Choudhry NK. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009 Mar; 47(3):319-25. PMID: 19194329; PMCID: PMC2704338.
  138. Shrank WH, Gleason PP, Canning C, Walters C, Heaton AH, Jan S, Patrick A, Brookhart MA, Schneeweiss S, Solomon DH, Avorn J, Choudhry NK. Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label. J Gen Intern Med. 2009 May; 24(5):570-8. PMID: 19247719; PMCID: PMC2669859.
  139. Avorn J, Shrank WH. Communicating drug benefits and risks effectively: there must be a better way. Ann Intern Med. 2009 Apr 21; 150(8):563-4. PMID: 19240226.
    View in: PubMed
  140. Shrank WH, Choudhry NK, Solomon DH, Snedden TM, Lee TH, Glynn RJ, Brown TV, Jolda C, Spetman M, Brookhart MA, Schneeweiss S, Avorn J. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. Am Heart J. 2009 Apr; 157(4):613-9. PMID: 19332186; PMCID: PMC2683845.
  141. Parikh S, Avorn J, Solomon DH. Pharmacological management of osteoporosis in nursing home populations: a systematic review. J Am Geriatr Soc. 2009 Feb; 57(2):327-34. PMID: 19207148.
    View in: PubMed
  142. Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death--how should we manage the risk? N Engl J Med. 2009 Jan 15; 360(3):294-6. PMID: 19144946.
    View in: PubMed
  143. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 2009; 32(11):1041-56. PMID: 19810776.
    View in: PubMed
  144. Kesselheim AS, Avorn J. Using patent data to assess the value of pharmaceutical innovation. J Law Med Ethics. 2009; 37(2):176-83. PMID: 19493065.
    View in: PubMed
  145. Choudhry NK, Zagorski B, Avorn J, Levin R, Sykora K, Laupacis A, Mamdani M. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis. Ann Pharmacother. 2008 Nov; 42(11):1563-72. PMID: 18827174.
    View in: PubMed
  146. Avorn J. Drug warnings that can cause fits--communicating risks in a data-poor environment. N Engl J Med. 2008 Sep 04; 359(10):991-4. PMID: 18768941.
    View in: PubMed
  147. Ting G, Schneeweiss S, Scranton R, Katz JN, Weinblatt ME, Young M, Avorn J, Solomon DH. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther. 2008; 10(4):R95. PMID: 18717997; PMCID: PMC2575609.
  148. Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum. 2008 Aug 15; 59(8):1097-104. PMID: 18668605; PMCID: PMC2884183.
  149. Setoguchi S, Schneeweiss S, Avorn J, Katz JN, Weinblatt ME, Levin R, Solomon DH. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J. 2008 Aug; 156(2):336-41. PMID: 18657665; PMCID: PMC3257055.
  150. Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6. PMID: 18585494; PMCID: PMC2697130.
  151. Avorn J. Coagulation and adulteration--building on science and policy lessons from 1905. N Engl J Med. 2008 Jun 05; 358(23):2429-31. PMID: 18525040.
    View in: PubMed
  152. Parikh S, Mogun H, Avorn J, Solomon DH. Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch Intern Med. 2008 May 26; 168(10):1111-5. PMID: 18504340.
    View in: PubMed
  153. Kesselheim AS, Avorn J. Pharmaceutical promotion to physicians and First Amendment rights. N Engl J Med. 2008 Apr 17; 358(16):1727-32. PMID: 18420505.
    View in: PubMed
  154. Avorn J, Shrank WH. Adverse Drug Reactions in Elderly People: A substantial cause of preventable illness. BMJ. 2008 Apr 26; 336(7650):956-7. PMID: 18397948; PMCID: PMC2335215.
  155. Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul; 19(7):1389-95. PMID: 18385423; PMCID: PMC2440305.
  156. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54. PMID: 18371553.
    View in: PubMed
  157. Wang PS, Patrick AR, Dormuth CR, Avorn J, Maclure M, Canning CF, Schneeweiss S. The impact of cost sharing on antidepressant use among older adults in British Columbia. Psychiatr Serv. 2008 Apr; 59(4):377-83. PMID: 18378836; PMCID: PMC2884181.
  158. Carpenter D, Zucker EJ, Avorn J. Drug-review deadlines and safety problems. N Engl J Med. 2008 Mar 27; 358(13):1354-61. PMID: 18367738.
    View in: PubMed
  159. Stürmer T, Rothman KJ, Avorn J. Pharmacoepidemiology and "in silico" drug evaluation: is there common ground? J Clin Epidemiol. 2008 Mar; 61(3):205-6. PMID: 18226742; PMCID: PMC2255561.
  160. Choudhry NK, Levin R, Avorn J. The economic consequences of non-evidence-based clopidogrel use. Am Heart J. 2008 May; 155(5):904-9. PMID: 18440340.
    View in: PubMed
  161. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008 Mar 11; 117(10):1261-8. PMID: 18285564; PMCID: PMC2722033.
  162. Avorn J, Choudhry NK. Using computer-based decision support to close the "know do" gap in lipid-lowering therapy. Circulation. 2008 Jan 22; 117(3):336-7. PMID: 18212297.
    View in: PubMed
  163. van Wijk BL, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008 Jan; 26(1):145-53. PMID: 18090552; PMCID: PMC2745820.
  164. Polinski JM, Cadarette SM, Arnold M, Katz JN, Finkelstein JS, Brookhart MA, Canning C, Avorn J, Solomon DH. High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania. Int Q Community Health Educ. 2008-2009; 29(3):223-40. PMID: 19720587; PMCID: PMC2885851.
  165. Wang PS, Schneeweiss S, Setoguchi S, Patrick A, Avorn J, Mogun H, Choudhry NK, Brookhart MA. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol. 2007 Dec; 27(6):707-10. PMID: 18004143.
    View in: PubMed
  166. Avorn J. In defense of pharmacoepidemiology--embracing the yin and yang of drug research. N Engl J Med. 2007 Nov 29; 357(22):2219-21. PMID: 18046025.
    View in: PubMed
  167. Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, Arnold M, Gauthier S, Avorn J. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007 Nov; 22(11):1808-15. PMID: 17645403.
    View in: PubMed
  168. Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care. 2007 Oct; 45(10 Supl 2):S38-43. PMID: 17909381.
    View in: PubMed
  169. Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care. 2007 Oct; 45(10 Supl 2):S158-65. PMID: 17909375; PMCID: PMC2265540.
  170. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007 Oct; 55 Suppl 2:S373-82. PMID: 17910560.
    View in: PubMed
  171. Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007 Oct; 45(10 Supl 2):S131-42. PMID: 17909372; PMCID: PMC2905666.
  172. Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, Petukhova MZ, Kessler RC. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA. 2007 Sep 26; 298(12):1401-11. PMID: 17895456; PMCID: PMC2859667.
  173. Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim AS, Avorn J, Shekelle P. The variability and quality of medication container labels. Arch Intern Med. 2007 Sep 10; 167(16):1760-5. PMID: 17846395.
    View in: PubMed
  174. Brookhart MA, Avorn J, Polinksi JM, Brown TV, Mogun H, Solomon DH. The medical license number accurately identifies the prescribing physician in a large pharmacy claims database. Med Care. 2007 Sep; 45(9):907-10. PMID: 17712263.
    View in: PubMed
  175. Solomon DH, Avorn J, Levin R, Brookhart MA. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis. 2008 May; 67(5):609-13. PMID: 17728328.
    View in: PubMed
  176. Avorn J. Keeping science on top in drug evaluation. N Engl J Med. 2007 Aug 16; 357(7):633-5. PMID: 17699813.
    View in: PubMed
  177. Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum. 2007 Aug 15; 57(6):928-34. PMID: 17665462.
    View in: PubMed
  178. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7. PMID: 17884362.
    View in: PubMed
  179. Shrank WH, Stedman M, Ettner SL, DeLapp D, Dirstine J, Brookhart MA, Fischer MA, Avorn J, Asch SM. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med. 2007 Sep; 22(9):1298-304. PMID: 17647066; PMCID: PMC2219782.
  180. Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64. PMID: 17530704.
    View in: PubMed
  181. Avorn J. Does adherence to medical therapy improve long-term survival after myocardial infarction? Nat Clin Pract Cardiovasc Med. 2007 Jul; 4(7):354-5. PMID: 17502879.
    View in: PubMed
  182. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007 Aug 01; 166(3):348-54. PMID: 17504779.
    View in: PubMed
  183. Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007 May-Jun; 26(3):731-40. PMID: 17485751.
    View in: PubMed
  184. Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, van Wijk BL, Cadarette SM, Canning CF, Solomon DH. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007 Apr 23; 167(8):847-52. PMID: 17452550.
    View in: PubMed
  185. Fischer MA, Morris CA, Winkelmayer WC, Avorn J. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6. PMID: 17452549.
    View in: PubMed
  186. Avorn J. Paying for drug approvals--who's using whom? N Engl J Med. 2007 Apr 26; 356(17):1697-700. PMID: 17435083.
    View in: PubMed
  187. Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007 May; 41(5):783-801. PMID: 17426075.
    View in: PubMed
  188. Winkelmayer WC, Mehta J, Chandraker A, Owen WF, Avorn J. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9. PMID: 17391130.
    View in: PubMed
  189. Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Performance of propensity score calibration--a simulation study. Am J Epidemiol. 2007 May 15; 165(10):1110-8. PMID: 17395595; PMCID: PMC1945235.
  190. Charytan DM, Setoguchi S, Solomon DH, Avorn J, Winkelmayer WC. Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45. PMID: 17342183.
    View in: PubMed
  191. van Wijk BL, Avorn J, Solomon DH, Klungel OH, Heerdink ER, de Boer A, Brookhart AM. Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study. J Hypertens. 2007 Mar; 25(3):689-97. PMID: 17278986.
    View in: PubMed
  192. Brookhart MA, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Patrick AR, Mogun H, Solmon DH. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med. 2007 Mar; 120(3):251-6. PMID: 17349448.
    View in: PubMed
  193. Avorn J. The marketplace can't give us the drug safety data we need. MedGenMed. 2007 Feb 09; 9(1):29. PMID: 17435636; PMCID: PMC1924999.
  194. Rothschild JM, McGurk S, Honour M, Lu L, McClendon AA, Srivastava P, Churchill WH, Kaufman RM, Avorn J, Cook EF, Bates DW. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007 Feb; 47(2):228-39. PMID: 17302768.
    View in: PubMed
  195. Avorn J. Every clinician deserves an un-sales rep. MedGenMed. 2007 Jan 19; 9(1):13. PMID: 17435622; PMCID: PMC1925003.
  196. Kesselheim AS, Avorn J. The role of litigation in defining drug risks. JAMA. 2007 Jan 17; 297(3):308-11. PMID: 17227983.
    View in: PubMed
  197. Patrick AR, Winkelmayer WC, Avorn J, Fischer MA. Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis. Pharmacoeconomics. 2007; 25(11):949-61. PMID: 17960953.
    View in: PubMed
  198. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood). 2007 Jan-Feb; 26(1):186-94. PMID: 17211028.
    View in: PubMed
  199. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007 Jan 02; 115(1):27-33. PMID: 17179016.
    View in: PubMed
  200. Winkelmayer WC, Fischer MA, Schneeweiss S, Levin R, Avorn J. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7. PMID: 17105523; PMCID: PMC1924742.
  201. Wang PS, Patrick A, Avorn J, Azocar F, Ludman E, McCulloch J, Simon G, Kessler R. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry. 2006 Dec; 63(12):1345-53. PMID: 17146009.
    View in: PubMed
  202. Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Dec; 54(12):3790-8. PMID: 17136752.
    View in: PubMed
  203. Avorn J. Dangerous deception--hiding the evidence of adverse drug effects. N Engl J Med. 2006 Nov 23; 355(21):2169-71. PMID: 17124012.
    View in: PubMed
  204. Avorn J. Review: good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortality. ACP J Club. 2006 Nov-Dec; 145(3):80. PMID: 17080992.
    View in: PubMed
  205. Kesselheim AS, Fischer MA, Avorn J. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Health Aff (Millwood). 2006 Nov-Dec; 25(6):1637-47. PMID: 17102189.
    View in: PubMed
  206. Winkelmayer WC, Zhang Z, Shahinfar S, Cooper ME, Avorn J, Brenner BM. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7. PMID: 17003295.
    View in: PubMed
  207. Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Sep; 54(9):2757-64. PMID: 16947774.
    View in: PubMed
  208. Kesselheim AS, Fischer MA, Avorn J. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Health Aff (Millwood). 2006 Jul-Aug; 25(4):1095-102. PMID: 16835191.
    View in: PubMed
  209. Fischer MA, Cheng H, Schneeweiss S, Avorn J, Solomon DH. Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review. Med Care. 2006 Jul; 44(7):658-63. PMID: 16799360.
    View in: PubMed
  210. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 2006 Dec; 65(12):1608-12. PMID: 16793844; PMCID: PMC1798453.
  211. Avorn J, Shrank W. Highlights and a hidden hazard--the FDA's new labeling regulations. N Engl J Med. 2006 Jun 08; 354(23):2409-11. PMID: 16760439.
    View in: PubMed
  212. Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol. 2006 Jul; 1(4):796-801. PMID: 17699289.
    View in: PubMed
  213. Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006 Aug; 59(8):819-28. PMID: 16828675.
    View in: PubMed
  214. Avorn J. Evaluating drug effects in the post-Vioxx world: there must be a better way. Circulation. 2006 May 09; 113(18):2173-6. PMID: 16684873.
    View in: PubMed
  215. Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54. PMID: 16751323.
    View in: PubMed
  216. Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 May; 54(5):1378-89. PMID: 16645966.
    View in: PubMed
  217. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006 Jun 15; 163(12):1149-56. PMID: 16624967; PMCID: PMC1513192.
  218. Schneeweiss S, Maclure M, Dormuth CR, Glynn RJ, Canning C, Avorn J. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clin Pharmacol Ther. 2006 Apr; 79(4):379-88. PMID: 16580906.
    View in: PubMed
  219. Avorn J. Part "D" for "defective"--the Medicare drug-benefit chaos. N Engl J Med. 2006 Mar 30; 354(13):1339-41. PMID: 16571877.
    View in: PubMed
  220. Sato M, Schneeweiss S, Scranton R, Katz JN, Weinblatt ME, Avorn J, Ting G, Shadick NA, Solomon DH. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res Ther. 2006; 8(3):R57. PMID: 16542499; PMCID: PMC1526615.
  221. Fischer MA, Avorn J. Educating Trainees about the Cost of Medications. Virtual Mentor. 2006 Mar 01; 8(3):142-6. PMID: 23232344.
    View in: PubMed
  222. Solomon DH, Avorn J, Wang PS, Vaillant G, Cabral D, Mogun H, Stürmer T. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum. 2006 Feb 15; 55(1):35-41. PMID: 16463409.
    View in: PubMed
  223. Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006 Feb 13; 166(3):332-7. PMID: 16476874.
    View in: PubMed
  224. Winkelmayer WC, Charytan DM, Levin R, Avorn J. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8. PMID: 16431259.
    View in: PubMed
  225. Kesselheim AS, Avorn J. Biomedical patents and the public's health: is there a role for eminent domain? JAMA. 2006 Jan 25; 295(4):434-7. PMID: 16434634.
    View in: PubMed
  226. Solomon DH, Finkelstein JS, Polinski JM, Arnold M, Licari A, Cabral D, Canning C, Avorn J, Katz JN. A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int. 2006; 17(5):760-7. PMID: 16432644.
    View in: PubMed
  227. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med. 2006 Jan 23; 166(2):155-60. PMID: 16432082.
    View in: PubMed
  228. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 01; 353(22):2335-41. PMID: 16319382.
    View in: PubMed
  229. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7. PMID: 16310574.
    View in: PubMed
  230. Solomon DH, Avorn J, Canning CF, Wang PS. Lipid levels and bone mineral density. Am J Med. 2005 Dec; 118(12):1414. PMID: 16378789.
    View in: PubMed
  231. Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA. Compliance with osteoporosis medications. Arch Intern Med. 2005 Nov 14; 165(20):2414-9. PMID: 16287772.
    View in: PubMed
  232. Brookhart MA, Solomon DH, Wang P, Glynn RJ, Avorn J, Schneeweiss S. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol. 2006 Jan; 59(1):18-25. PMID: 16360557.
    View in: PubMed
  233. Stürmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006 May; 59(5):437-47. PMID: 16632131; PMCID: PMC1448214.
  234. Perlis RH, Ganz DA, Avorn J, Schneeweiss S, Glynn RJ, Smoller JW, Wang PS. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model. J Clin Psychopharmacol. 2005 Oct; 25(5):427-34. PMID: 16160617.
    View in: PubMed
  235. Avorn J. FDA standards--good enough for government work? N Engl J Med. 2005 Sep 08; 353(10):969-72. PMID: 16148281.
    View in: PubMed
  236. Setoguchi S, Avorn J, Schneeweiss S. Statins and the risk of colorectal cancer. N Engl J Med. 2005 Sep 01; 353(9):952-4; author reply 952-4. PMID: 16136709.
    View in: PubMed
  237. Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32. PMID: 16112040.
    View in: PubMed
  238. Avorn J, Schneeweiss S, Sudarsky LR, Benner J, Kiyota Y, Levin R, Glynn RJ. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol. 2005 Aug; 62(8):1242-8. PMID: 16087765.
    View in: PubMed
  239. Avorn J. Sending pharma better signals. Science. 2005 Jul 29; 309(5735):669. PMID: 16051753.
    View in: PubMed
  240. Stürmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol. 2005 Aug 01; 162(3):279-89. PMID: 15987725; PMCID: PMC1444885.
  241. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9. PMID: 15983239.
    View in: PubMed
  242. Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 01; 41(3):301-7. PMID: 16007524.
    View in: PubMed
  243. Avorn J. Torcetrapib and atorvastatin--should marketing drive the research agenda? N Engl J Med. 2005 Jun 23; 352(25):2573-6. PMID: 15972861.
    View in: PubMed
  244. Choudhry NK, Avorn J. Over-the-counter statins. Ann Intern Med. 2005 Jun 07; 142(11):910-3. PMID: 15941698.
    View in: PubMed
  245. Putnam KG, Bohn RL, Ewenstein BM, Winkelmayer WC, Avorn J. A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia. 2005 May; 11(3):261-9. PMID: 15876272.
    View in: PubMed
  246. Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 01; 161(9):891-8. PMID: 15840622; PMCID: PMC1407370.
  247. Peterson JF, Kuperman GJ, Shek C, Patel M, Avorn J, Bates DW. Guided prescription of psychotropic medications for geriatric inpatients. Arch Intern Med. 2005 Apr 11; 165(7):802-7. PMID: 15824302.
    View in: PubMed
  248. Solomon DH, Finkelstein JS, Wang PS, Avorn J. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf. 2005 Apr; 14(4):219-26. PMID: 15386702.
    View in: PubMed
  249. Burgener M, Arnold M, Katz JN, Polinski JM, Cabral D, Avorn J, Solomon DH. Older adults' knowledge and beliefs about osteoporosis: results of semistructured interviews used for the development of educational materials. J Rheumatol. 2005 Apr; 32(4):673-7. PMID: 15801024.
    View in: PubMed
  250. Wang PS, Schneeweiss S, Brookhart MA, Glynn RJ, Mogun H, Patrick AR, Avorn J. Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol. 2005 Apr; 25(2):118-26. PMID: 15738742.
    View in: PubMed
  251. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005 Apr; 58(4):323-37. PMID: 15862718.
    View in: PubMed
  252. Kesselheim AS, Avorn J. University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA. 2005 Feb 16; 293(7):850-4. PMID: 15713775.
    View in: PubMed
  253. Cabral D, Katz JN, Weinblatt ME, Ting G, Avorn J, Solomon DH. Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel. Arthritis Rheum. 2005 Feb 15; 53(1):61-6. PMID: 15696560.
    View in: PubMed
  254. Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005 Feb; 80(2):194-202. PMID: 15704774.
    View in: PubMed
  255. Solomon DH, Brookhart MA, Polinski J, Katz JN, Cabral D, Licari A, Avorn J. Osteoporosis action: design of the healthy bones project trial. Contemp Clin Trials. 2005 Feb; 26(1):78-94. PMID: 15837454.
    View in: PubMed
  256. Solomon DH, Avorn J. Coxibs, science, and the public trust. Arch Intern Med. 2005 Jan 24; 165(2):158-60. PMID: 15668360.
    View in: PubMed
  257. Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology. 2005 Jan; 16(1):17-24. PMID: 15613941.
    View in: PubMed
  258. Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005 Jan; 58(1):98-102. PMID: 15649677.
    View in: PubMed
  259. Avorn J, Winkelmayer WC. Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004 Dec 14; 110(24 Suppl 1):IV25-32. PMID: 15598645.
    View in: PubMed
  260. Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004 Nov 18; 351(21):2187-94. PMID: 15548779.
    View in: PubMed
  261. Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med. 2004 Sep 27; 164(17):1858-64. PMID: 15451760.
    View in: PubMed
  262. Avorn J, Knight E, Ganz DA, Schneeweiss S. Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction. Am J Cardiol. 2004 Aug 15; 94(4):415-20. PMID: 15325921.
    View in: PubMed
  263. van Eijk ME, Paes AH, Porsius A, Avorn J, de Boer A. Pre-randomization decisions and group stratification in a randomized controlled trial to improve prescribing. Pharm World Sci. 2004 Aug; 26(4):227-31. PMID: 15446780.
    View in: PubMed
  264. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004 Aug 9-23; 164(15):1641-9. PMID: 15302634.
    View in: PubMed
  265. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004 Jul; 148(1):99-104. PMID: 15215798.
    View in: PubMed
  266. Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, Solomon DH. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004 Jul; 19(7):783-90. PMID: 15209594; PMCID: PMC1492483.
  267. Solomon DH, Schneeweiss S, Levin R, Avorn J. Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004 Aug; 44(2):140-5. PMID: 15226279.
    View in: PubMed
  268. Wang PS, Ganz DA, Benner JS, Glynn RJ, Avorn J. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. J Ment Health Policy Econ. 2004 Jun; 7(2):77-85. PMID: 15208468.
    View in: PubMed
  269. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004 May 04; 140(9):714-20. PMID: 15126255.
    View in: PubMed
  270. Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R, Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004 May; 19(5 Pt 1):444-50. PMID: 15109342; PMCID: PMC1492245.
  271. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA. 2004 Apr 21; 291(15):1850-6. PMID: 15100203.
    View in: PubMed
  272. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 2004 May 04; 109(17):2068-73. PMID: 15096449.
    View in: PubMed
  273. Fischer MA, Avorn J. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit. Pharmacoepidemiol Drug Saf. 2004 Apr; 13(4):207-14. PMID: 15255087.
    View in: PubMed
  274. Wang PS, Schneeweiss S, Glynn RJ, Mogun H, Avorn J. Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Ann Epidemiol. 2004 Apr; 14(4):296-303. PMID: 15066610.
    View in: PubMed
  275. Solomon DH, Avorn J, Warsi A, Brown CH, Martin S, Martin TL, Wright J, Burgener M, Katz JN. Which patients with knee problems are likely to benefit from nonarthroplasty surgery? Development of a clinical prediction rule. Arch Intern Med. 2004 Mar 08; 164(5):509-13. PMID: 15006827.
    View in: PubMed
  276. Schneeweiss S, Maclure M, Carleton B, Glynn RJ, Avorn J. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ. 2004 Mar 06; 328(7439):560. PMID: 14982865; PMCID: PMC381049.
  277. Bohn RL, Aledort LM, Putnam KG, Ewenstein BM, Mogun H, Avorn J. The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia. 2004 Jan; 10(1):63-8. PMID: 14962222.
    View in: PubMed
  278. Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J. An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre. Drug Saf. 2004; 27(15):1253-61. PMID: 15588120.
    View in: PubMed
  279. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9. PMID: 14971118.
    View in: PubMed
  280. Avorn J. The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation. Pharmacoeconomics. 2004; 22(2 Suppl 2):81-6. PMID: 15660480.
    View in: PubMed
  281. Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med. 2003 Dec 15; 115(9):715-20. PMID: 14693324.
    View in: PubMed
  282. Fischer MA, Solomon DH, Teich JM, Avorn J. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med. 2003 Nov 24; 163(21):2585-9. PMID: 14638558.
    View in: PubMed
  283. Avorn J, Patel M, Levin R, Winkelmayer WC. Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42. PMID: 14555577.
    View in: PubMed
  284. Solomon DH, Finkelstein JS, Katz JN, Mogun H, Avorn J. Underuse of osteoporosis medications in elderly patients with fractures. Am J Med. 2003 Oct 01; 115(5):398-400. PMID: 14553876.
    View in: PubMed
  285. Morris CA, Avorn J. Internet marketing of herbal products. JAMA. 2003 Sep 17; 290(11):1505-9. PMID: 13129992.
    View in: PubMed
  286. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9. PMID: 12911555.
    View in: PubMed
  287. Desai AS, Solomon DH, Stone PH, Avorn J. Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris. Am J Cardiol. 2003 Aug 15; 92(4):363-7. PMID: 12914862.
    View in: PubMed
  288. Fischer MA, Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res. 2003 Aug; 38(4):1051-63. PMID: 12968816; PMCID: PMC1360932.
  289. Warsi A, LaValley MP, Wang PS, Avorn J, Solomon DH. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum. 2003 Aug; 48(8):2207-13. PMID: 12905474.
    View in: PubMed
  290. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug; 38(4):1103-20. PMID: 12968819; PMCID: PMC1360935.
  291. Winkelmayer WC, Levin R, Avorn J. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003 May; 63(5):1836-42. PMID: 12675861.
    View in: PubMed
  292. Solomon DH, Katz JN, Carrino JA, Schaffer JL, Bohn RL, Mogun H, Avorn J. Trends in knee magnetic resonance imaging. Med Care. 2003 May; 41(5):687-92. PMID: 12719693.
    View in: PubMed
  293. Parr KG, Patel MA, Dekker R, Levin R, Glynn R, Avorn J, Morse DS. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth. 2003 Apr; 17(2):176-81. PMID: 12698398.
    View in: PubMed
  294. Mantel-Teeuwisse AK, Verschuren WM, Klungel OH, Kromhout D, Lindemans AD, Avorn J, Porsius AJ, de Boer A. Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol. 2003 Apr; 55(4):389-97. PMID: 12680888; PMCID: PMC1884230.
  295. Solomon DH, Glynn RJ, Bohn R, Levin R, Avorn J. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients. J Rheumatol. 2003 Apr; 30(4):792-8. PMID: 12672201.
    View in: PubMed
  296. Solomon DH, Avorn J. Pharmacoepidemiology and rheumatic diseases: 2001-2002. Curr Opin Rheumatol. 2003 Mar; 15(2):122-6. PMID: 12598798.
    View in: PubMed
  297. LeLorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA. Bringing epidemiology into drug utilisation research. Pharmacoepidemiol Drug Saf. 2003 Mar; 12(2):153-6. PMID: 12642980.
    View in: PubMed
  298. Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 Feb 15; 21(4):602-6. PMID: 12586795.
    View in: PubMed
  299. Winkelmayer WC, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003 Feb; 14(2):486-92. PMID: 12538751.
    View in: PubMed
  300. Solomon DH, Avorn J. Do gastroprotective drugs prevent NSAID toxicity? J Rheumatol. 2003 Jan; 30(1):203; author reply 203-4. PMID: 12508416.
    View in: PubMed
  301. Avorn J. Advertising and prescription drugs: promotion, education, and the public's health. Health Aff (Millwood). 2003 Jan-Jun; Suppl Web Exclusives:W3-104-8. PMID: 14527239.
    View in: PubMed
  302. Winkelmayer WC, Levin R, Avorn J. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis. 2003 Jan; 41(1):84-9. PMID: 12500224.
    View in: PubMed
  303. Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. Pharmacoepidemiol Drug Saf. 2003 Jan-Feb; 12(1):67-70. PMID: 12616850.
    View in: PubMed
  304. Avorn J, Benner J, Ford I, Ganz DA, Gaw A, Glynn RJ, Jackson J, Lagaay AM, Schneeweiss S, Walley T, Wang PS. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Control Clin Trials. 2002 Dec; 23(6):757-73. PMID: 12505250.
    View in: PubMed
  305. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry. 2002 Dec; 59(12):1147-54. PMID: 12470131.
    View in: PubMed
  306. Schneeweiss S, Maclure M, Dormuth C, Avorn J. Pharmaceutical cost containment with reference-based pricing: time for refinements. CMAJ. 2002 Nov 26; 167(11):1250-1. PMID: 12451080; PMCID: PMC134136.
  307. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6. PMID: 12230424.
    View in: PubMed
  308. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62. PMID: 12191980.
    View in: PubMed
  309. Winkelmayer WC, Owen W, Glynn RJ, Levin R, Avorn J. Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95. PMID: 12213139; PMCID: PMC1495089.
  310. Solomon DH, Glynn RJ, Avorn J. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002 Jul 06; 360(9326):90. PMID: 12114070.
    View in: PubMed
  311. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002 Jul; 17(7):504-11. PMID: 12133140; PMCID: PMC1495082.
  312. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002 Jul 24-31; 288(4):455-61. PMID: 12132975.
    View in: PubMed
  313. Avorn J, Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, Owen W. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6. PMID: 12160919.
    View in: PubMed
  314. Winkelmayer WC, Glynn RJ, Levin R, Mittleman MA, Pliskin JS, Avorn J. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23. PMID: 12131688.
    View in: PubMed
  315. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002 Jul; 58(4):285-91. PMID: 12136375.
    View in: PubMed
  316. Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol. 2002 Jun; 22(3):236-43. PMID: 12006892.
    View in: PubMed
  317. Solomon DH, Glynn RJ, Levin R, Avorn J. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med. 2002 May 27; 162(10):1099-104. PMID: 12020178.
    View in: PubMed
  318. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 01; 94(9):652-61. PMID: 11983753.
    View in: PubMed
  319. Ganz DA, Kuntz KM, Benner JS, Avorn J. Correction: cost-effectiveness of statins in older patients with myocardial infarction. Ann Intern Med. 2002 Apr 16; 136(8):635. PMID: 11955042.
    View in: PubMed
  320. Solomon DH, Ganz DA, Avorn J, Glynn RJ, Knight EL, Gibson CM, Stone PH. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol. 2002 Feb; 55(2):121-8. PMID: 11809349.
    View in: PubMed
  321. Avorn J. Balancing the cost and value of medications: the dilemma facing clinicians. Pharmacoeconomics. 2002; 20 Suppl 3:67-72. PMID: 12457426.
    View in: PubMed
  322. Ewenstein BM, Avorn J, Putnam KG, Bohn RL. Porcine factor VIII: pharmacoeconomics of inhibitor therapy. Haemophilia. 2002 Jan; 8 Suppl 1:13-6; discussion 28-32. PMID: 11882077.
    View in: PubMed
  323. Wang PS, Levin R, Zhao SZ, Avorn J. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients. J Am Geriatr Soc. 2002 Jan; 50(1):117-24. PMID: 12028256.
    View in: PubMed
  324. Avorn J. Improving drug use in elderly patients: getting to the next level. JAMA. 2001 Dec 12; 286(22):2866-8. PMID: 11735764.
    View in: PubMed
  325. Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84. PMID: 11728948.
    View in: PubMed
  326. van Eijk ME, Krist LF, Avorn J, Porsius A, de Boer A. Do the research goal and databases match? A checklist for a systematic approach. Health Policy. 2001 Dec; 58(3):263-74. PMID: 11641003.
    View in: PubMed
  327. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001 Dec; 49(12):1685-90. PMID: 11844004.
    View in: PubMed
  328. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001 Nov 01; 154(9):854-64. PMID: 11682368.
    View in: PubMed
  329. Avorn J. Unhealthy ageing: functional and socioeconomic impact. Eur Heart J. 2001 Nov; 3 Suppl N:N3-5. PMID: 11913486.
    View in: PubMed
  330. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology. 2001 Nov; 12(6):682-9. PMID: 11679797.
    View in: PubMed
  331. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001 Oct 16; 135(8 Pt 2):703-10. PMID: 11601953.
    View in: PubMed
  332. Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, Avorn J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 2001 Oct; 38(4):969-76. PMID: 11583866.
    View in: PubMed
  333. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001 Oct; 38(4):809-14. PMID: 11641291.
    View in: PubMed
  334. Winkelmayer WC, Glynn RJ, Levin R, Owen W, Avorn J. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54. PMID: 11576371.
    View in: PubMed
  335. Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001 Aug 13-27; 161(15):1897-902. PMID: 11493132.
    View in: PubMed
  336. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001 Jul 09; 161(13):1629-34. PMID: 11434795.
    View in: PubMed
  337. Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J. Antidepressant use and the risk of breast cancer: a non-association. J Clin Epidemiol. 2001 Jul; 54(7):728-34. PMID: 11438414.
    View in: PubMed
  338. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001 Jun; 158(6):892-8. PMID: 11384896.
    View in: PubMed
  339. Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J. Finding incident breast cancer cases through US claims data and a state cancer registry. Cancer Causes Control. 2001 Apr; 12(3):257-65. PMID: 11405331.
    View in: PubMed
  340. van Eijk ME, Avorn J, Porsius AJ, de Boer A. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ. 2001 Mar 17; 322(7287):654-7. PMID: 11250852; PMCID: PMC26547.
  341. Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000 Nov; 15(11):776-81. PMID: 11119169; PMCID: PMC1495613.
  342. Knight EL, Glynn RJ, Levin R, Ganz DA, Avorn J. Failure of evidence-based medicine in the treatment of hypertension in older patients. J Gen Intern Med. 2000 Oct; 15(10):702-9. PMID: 11089713; PMCID: PMC1495604.
  343. Colowick AB, Bohn RL, Avorn J, Ewenstein BM. Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper. Blood. 2000 Sep 01; 96(5):1698-702. PMID: 10961866.
    View in: PubMed
  344. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000 Aug 01; 109(2):87-94. PMID: 10967148.
    View in: PubMed
  345. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med. 2000 Jul 18; 133(2):128-35. PMID: 10896639.
    View in: PubMed
  346. Bérard A, Solomon DH, Avorn J. Patterns of drug use in rheumatoid arthritis. J Rheumatol. 2000 Jul; 27(7):1648-55. PMID: 10914846.
    View in: PubMed
  347. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000 Jun 28; 283(24):3211-6. PMID: 10866868.
    View in: PubMed
  348. van Eijk ME, Bahri P, Dekker G, Herings RM, Porsius A, Avorn J, de Boer A. Use of prevalence and incidence measures to describe age-related prescribing of antidepressants with and without anticholinergic effects. J Clin Epidemiol. 2000 Jun; 53(6):645-51. PMID: 10880785.
    View in: PubMed
  349. Wang PS, Walker A, Tsuang M, Orav EJ, Levin R, Avorn J. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. J Clin Epidemiol. 2000 Jun; 53(6):571-8. PMID: 10880775.
    View in: PubMed
  350. Ganz DA, Kuntz KM, Jacobson GA, Avorn J. Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med. 2000 May 16; 132(10):780-7. PMID: 10819700.
    View in: PubMed
  351. Bohn RL, Gurwitz JH, Yeomans SM, Glynn RJ, Pasquale LR, Walker AM, Avorn J. Which patients are treated for glaucoma? An observational analysis. J Glaucoma. 2000 Feb; 9(1):38-44. PMID: 10708230.
    View in: PubMed
  352. Avorn J. Post-modern drug evaluation. The deconstruction of evidence-based regulation. Pharmacoeconomics. 2000; 18 Suppl 1:15-20. PMID: 11151305.
    View in: PubMed
  353. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J. 1999 Nov; 138(5 Pt 1):849-55. PMID: 10539815.
    View in: PubMed
  354. Bohn RL, Colowick AB, Avorn J. Probabilities, costs, and outcomes: methodological issues in modelling haemophilia treatment. Haemophilia. 1999 Nov; 5(6):374-7. PMID: 10583522.
    View in: PubMed
  355. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol. 1999 Aug; 52(8):781-90. PMID: 10465323.
    View in: PubMed
  356. Pan CX, Glynn RJ, Mogun H, Choodnovskiy I, Avorn J. Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc. 1999 Jun; 47(6):730-3. PMID: 10366176.
    View in: PubMed
  357. Solomon DH, Katz JN, Bohn R, Mogun H, Avorn J. Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med. 1999 May; 14(5):310-4. PMID: 10337041; PMCID: PMC1496575.
  358. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999 Mar 15; 149(6):541-9. PMID: 10084243.
    View in: PubMed
  359. Brown NJ, Griffin MR, Ray WA, Meredith S, Beers MH, Marren J, Robles M, Stergachis A, Wood AJ, Avorn J. A model for improving medication use in home health care patients. J Am Pharm Assoc (Wash). 1998 Nov-Dec; 38(6):696-702. PMID: 9861787.
    View in: PubMed
  360. Avorn J. Depression in the elderly--falls and pitfalls. N Engl J Med. 1998 Sep 24; 339(13):918-20. PMID: 9744979.
    View in: PubMed
  361. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998 May 13; 279(18):1458-62. PMID: 9600480.
    View in: PubMed
  362. Bohn RL, Avorn J, Glynn RJ, Choodnovskiy I, Haschemeyer R, Aledort LM. Prophylactic use of factor VIII: an economic evaluation. Thromb Haemost. 1998 May; 79(5):932-7. PMID: 9609224.
    View in: PubMed
  363. Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care. 1998 Mar; 36(3):357-69. PMID: 9520960.
    View in: PubMed
  364. Avorn J. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1998 Feb 19; 338(8):543-4; author reply 544-5. PMID: 9471553.
    View in: PubMed
  365. Avorn J. Healthcare and the tooth fairy. A merger that won't result in 'smarter' medicine. Pharmacoeconomics. 1998; 14 Suppl 1:33-6. PMID: 10186479.
    View in: PubMed
  366. Avorn J. Including elderly people in clinical trials. BMJ. 1997 Oct 25; 315(7115):1033-4. PMID: 9366725; PMCID: PMC2127680.
  367. Dillon KA, Putnam KG, Avorn JL. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine. JAMA. 1997 Oct 22-29; 278(16):1320. PMID: 9343461.
    View in: PubMed
  368. Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc. 1997 Sep; 45(9):1060-5. PMID: 9288012.
    View in: PubMed
  369. Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997 Aug; 50(8):953-9. PMID: 9291881.
    View in: PubMed
  370. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997 Jul; 10(7 Pt 1):697-704. PMID: 9234822.
    View in: PubMed
  371. Monette J, Mogun H, Bohn RL, Avorn J. Concurrent use of antiulcerative agents. J Clin Gastroenterol. 1997 Jun; 24(4):207-13. PMID: 9252842.
    View in: PubMed
  372. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 1997 May 12; 157(9):978-84. PMID: 9140268.
    View in: PubMed
  373. Kalish SC, Bohn RL, Avorn J. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Med Care. 1997 Jan; 35(1):32-48. PMID: 8998201.
    View in: PubMed
  374. Avorn J. Putting adverse drug events into perspective. JAMA. 1997 Jan 22-29; 277(4):341-2. PMID: 9002498.
    View in: PubMed
  375. Monane M, Gurwitz JH, Bohn RL, Glynn RJ, Levin R, Monette J, Avorn J. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc. 1997 Jan; 45(1):71-5. PMID: 8994491.
    View in: PubMed
  376. Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med. 1997 Jan; 12(1):63-6. PMID: 9034948; PMCID: PMC1497059.
  377. Huttin C, Avorn J. Drug expenditures for hypertension: an empirical test of an economic model in a French population. Cah Sociol Demogr Med. 1997 Jan-Mar; 37(1):33-52. PMID: 9239318.
    View in: PubMed
  378. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996 Dec; 86(12):1805-8. PMID: 9003143; PMCID: PMC1380739.
  379. Monane M, Avorn J. Medications and falls. Causation, correlation, and prevention. Clin Geriatr Med. 1996 Nov; 12(4):847-58. PMID: 8890119.
    View in: PubMed
  380. Andrews EA, Avorn J, Bortnichak EA, Chen R, Dai WS, Dieck GS, Edlavitch S, Freiman J, Mitchell AA, Nelson RC, Neutel CI, Stergachis A, Strom BL, Walker AM. Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf. 1996 Sep; 5(5):333-8. PMID: 15073820.
    View in: PubMed
  381. Monane M, Kanter DS, Glynn RJ, Avorn J. Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol. 1996 Sep; 53(9):875-80. PMID: 8815852.
    View in: PubMed
  382. Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, Avorn J. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996 Mar; 51(2):M74-9. PMID: 8612107.
    View in: PubMed
  383. Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med. 1996 Feb 12; 156(3):315-20. PMID: 8572842.
    View in: PubMed
  384. Monane M, Glynn RJ, Avorn J. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther. 1996 Jan; 59(1):83-92. PMID: 8549038.
    View in: PubMed
  385. Avorn J. Practice-based outcomes research: crucial, feasible, and neglected. Pediatrics. 1996 Jan; 97(1):113-4. PMID: 8545203.
    View in: PubMed
  386. Avorn J. The effect of cranberry juice on the presence of bacteria and white blood cells in the urine of elderly women. What is the role of bacterial adhesion? Adv Exp Med Biol. 1996; 408:185-6. PMID: 8895791.
    View in: PubMed
  387. Avorn J. Drug use in academic medical centres in an era of ferment. Pharmacoeconomics. 1996; 10 Suppl 2:124-9. PMID: 10163429.
    View in: PubMed
  388. Avorn J, Gurwitz JH, Bohn RL, Mogun H, Monane M, Walker A. Increased incidence of levodopa therapy following metoclopramide use. JAMA. 1995 Dec 13; 274(22):1780-2. PMID: 7500509.
    View in: PubMed
  389. Cleary PD, Van Devanter N, Steilen M, Stuart A, Shipton-Levy R, McMullen W, Rogers TF, Singer E, Avorn J, Pindyck J. A randomized trial of an education and support program for HIV-infected individuals. AIDS. 1995 Nov; 9(11):1271-8. PMID: 8561981.
    View in: PubMed
  390. Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Correlates of regular laxative use by frail elderly persons. Am J Med. 1995 Nov; 99(5):513-8. PMID: 7485209.
    View in: PubMed
  391. Soloman DH, Avorn J. Gastrointestinal complications of nonsteroidal antiinflammatory drugs: prophylactic and therapeutic strategies. Am J Med. 1995 Oct; 99(4):441-3. PMID: 7573107.
    View in: PubMed
  392. Monette J, Gurwitz JH, Avorn J. Epidemiology of adverse drug events in the nursing home setting. Drugs Aging. 1995 Sep; 7(3):203-11. PMID: 8535050.
    View in: PubMed
  393. Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J Am Geriatr Soc. 1995 Sep; 43(9):967-73. PMID: 7657936.
    View in: PubMed
  394. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med. 1995 Aug 01; 123(3):195-204. PMID: 7598302.
    View in: PubMed
  395. Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med. 1995 Jul; 99(1):48-54. PMID: 7598142.
    View in: PubMed
  396. Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995 Jun; 43(6):618-22. PMID: 7775718.
    View in: PubMed
  397. Kalish SC, Gurwitz JH, Krumholz HM, Avorn J. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. J Gen Intern Med. 1995 Jun; 10(6):321-30. PMID: 7562123.
    View in: PubMed
  398. Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension. 1995 May; 25(5):1045-51. PMID: 7737714.
    View in: PubMed
  399. Avorn J. Medication use and the elderly: current status and opportunities. Health Aff (Millwood). 1995; 14(1):276-86. PMID: 7657215.
    View in: PubMed
  400. Ross-Degnan D, Soumerai SB, Avorn J, Bohn RL, Bright R, Aledort LM. Hemophilia home treatment. Economic analysis and implications for health policy. Int J Technol Assess Health Care. 1995; 11(2):327-44. PMID: 7790175.
    View in: PubMed
  401. Avorn J. Drug regulation and drug information--who should do what to whom? Am J Public Health. 1995 Jan; 85(1):18-9. PMID: 7832255; PMCID: PMC1615276.
  402. Avorn J. The prescription as final common pathway. Int J Technol Assess Health Care. 1995; 11(3):384-90. PMID: 7591540.
    View in: PubMed
  403. Gurwitz JH, Field TS, Glynn RJ, Manson JE, Avorn J, Taylor JO, Hennekens CH. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. J Am Geriatr Soc. 1994 Dec; 42(12):1235-40. PMID: 7983284.
    View in: PubMed
  404. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994 Sep 14; 272(10):781-6. PMID: 8078142.
    View in: PubMed
  405. Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc. 1994 Sep; 42(9):947-52. PMID: 8064102.
    View in: PubMed
  406. Glickman L, Bruce EA, Caro FG, Avorn J. Physicians' knowledge of drug costs for the elderly. J Am Geriatr Soc. 1994 Sep; 42(9):992-6. PMID: 8064111.
    View in: PubMed
  407. Avorn J, Monane M, Everitt DE, Beers MH, Fields D. Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication. Arch Intern Med. 1994 May 23; 154(10):1113-7. PMID: 7910451.
    View in: PubMed
  408. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994 Mar 09; 271(10):751-4. PMID: 8093138.
    View in: PubMed
  409. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994 Feb 28; 154(4):433-7. PMID: 8117176.
    View in: PubMed
  410. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994 Jan 10; 154(1):97-101. PMID: 8267494.
    View in: PubMed
  411. Pickering TD, Gurwitz JH, Zaleznik D, Noonan JP, Avorn J. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. J Am Geriatr Soc. 1994 Jan; 42(1):28-32. PMID: 8277111.
    View in: PubMed
  412. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994 Jan; 55(1):76-83. PMID: 7905370.
    View in: PubMed
  413. Bohn RL, Glynn RJ, Gurwitz JH, Everitt DE, Gilden D, Avorn J. Patterns of glaucoma medication use in the elderly: 1980-1990. J Glaucoma. 1994; 3(3):259-64. PMID: 19920606.
    View in: PubMed
  414. Avorn J. Balancing costs, efficacy, and side effects. Pharmacoeconomics. 1994; 6 Suppl 1:63-6. PMID: 10172483.
    View in: PubMed
  415. Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med. 1993 Dec 30; 329(27):2029-32. PMID: 8018139.
    View in: PubMed
  416. Salem-Schatz SR, Avorn J, Soumerai SB. Influence of knowledge and attitudes on the quality of physicians' transfusion practice. Med Care. 1993 Oct; 31(10):868-78. PMID: 8412390.
    View in: PubMed
  417. Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Choodnovskiy I, Avorn J. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993 Sep 15; 138(6):395-406. PMID: 8213745.
    View in: PubMed
  418. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational outreach to improve blood transfusion practice. JAMA. 1993 Aug 25; 270(8):961-6. PMID: 8123097.
    View in: PubMed
  419. Bohn RL, Avorn J. Cost-effectiveness--can it be measured? Semin Hematol. 1993 Jul; 30(3 Suppl 2):20-3. PMID: 8367739.
    View in: PubMed
  420. Soumerai SB, Avorn J, Taylor WC, Wessels M, Maher D, Hawley SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care. 1993 Jun; 31(6):552-8. PMID: 8502003.
    View in: PubMed
  421. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993 May; 83(5):711-6. PMID: 8484454; PMCID: PMC1694682.
  422. Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R, Steilen M, Stuart A, Avorn J, Pindyck J. Depressive symptoms in blood donors notified of HIV infection. Am J Public Health. 1993 Apr; 83(4):534-9. PMID: 8460730; PMCID: PMC1694482.
  423. Monane M, Avorn J, Beers MH, Everitt DE. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med. 1993 Mar 08; 153(5):633-8. PMID: 8439226.
    View in: PubMed
  424. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993 Feb 15; 118(4):273-8. PMID: 8420444.
    View in: PubMed
  425. Avorn J, Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Everitt DE, Gilden D, Choodnovskiy I. Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma. J Glaucoma. 1993; 2(3):158-65. PMID: 19920512.
    View in: PubMed
  426. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992 Sep 16; 268(11):1417-22. PMID: 1512909.
    View in: PubMed
  427. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992 Jul 16; 327(3):168-73. PMID: 1608408.
    View in: PubMed
  428. Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med. 1992 Jun 01; 116(11):901-4. PMID: 1580446.
    View in: PubMed
  429. Kuchel GA, Avorn J, Reed MJ, Fields D. Cardiovascular responses to phlebotomy and sitting in middle-aged and elderly subjects. Arch Intern Med. 1992 Feb; 152(2):366-70. PMID: 1739368.
    View in: PubMed
  430. Beers MH, Avorn J, Soumerai S, Hawley SL, Drobnyk G. Computer-assisted drug data collection. J Med Syst. 1992 Feb; 16(1):1-6. PMID: 1645043.
    View in: PubMed
  431. Avorn J. Improving the quality and cost-effectiveness of prescribing. Pharmacoeconomics. 1992; 1(Suppl 1):45-8. PMID: 10146931.
    View in: PubMed
  432. Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R, Steilen M, Stuart A, Avorn J, Pindyck J. Behavior changes after notification of HIV infection. Am J Public Health. 1991 Dec; 81(12):1586-90. PMID: 1746654; PMCID: PMC1405297.
  433. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin Tj, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991 Oct 10; 325(15):1072-7. PMID: 1891009.
    View in: PubMed
  434. Everitt DE, Fields DR, Soumerai SS, Avorn J. Resident behavior and staff distress in the nursing home. J Am Geriatr Soc. 1991 Aug; 39(8):792-8. PMID: 2071810.
    View in: PubMed
  435. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991 Jun 01; 114(11):956-66. PMID: 2024864.
    View in: PubMed
  436. Avorn J, Everitt DE, Baker MW. The neglected medical history and therapeutic choices for abdominal pain. A nationwide study of 799 physicians and nurses. Arch Intern Med. 1991 Apr; 151(4):694-8. PMID: 2012450.
    View in: PubMed
  437. Avorn J. Epidemiology in Plato's cave: claims data and clinical reality. J Clin Epidemiol. 1991; 44(9):867-9. PMID: 1890429.
    View in: PubMed
  438. Cleary PD, Van Devanter N, Rogers TF, Singer E, Avorn J, Pindyck J. Trends in sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. AIDS Educ Prev. 1991; 3(1):60-71. PMID: 2036292.
    View in: PubMed
  439. Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol. 1990 Nov; 11(11):578-83. PMID: 2124233.
    View in: PubMed
  440. Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med. 1990 Sep; 89(3):357-62. PMID: 2393038.
    View in: PubMed
  441. Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA. 1990 Jul 25; 264(4):471-5. PMID: 2366280.
    View in: PubMed
  442. Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. JAMA. 1990 Jul 25; 264(4):476-83. PMID: 2366281.
    View in: PubMed
  443. Learman LA, Avorn J, Everitt DE, Rosenthal R. Pygmalion in the nursing home. The effects of caregiver expectations on patient outcomes. J Am Geriatr Soc. 1990 Jul; 38(7):797-803. PMID: 2196306.
    View in: PubMed
  444. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc. 1990 May; 38(5):542-52. PMID: 2185295.
    View in: PubMed
  445. Avorn J. Reporting drug side effects: signals and noise. JAMA. 1990 Apr 04; 263(13):1823. PMID: 2313853.
    View in: PubMed
  446. Avorn J. Medicaid-based pharmacoepidemiology: claims and counterclaims. Epidemiology. 1990 Mar; 1(2):98-100. PMID: 2073512.
    View in: PubMed
  447. Soumerai SB, Ross-Degnan D, Gortmaker S, Avorn J. Withdrawing payment for nonscientific drug therapy. Intended and unexpected effects of a large-scale natural experiment. JAMA. 1990 Feb 09; 263(6):831-9. PMID: 2404151.
    View in: PubMed
  448. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990 Jan 26; 263(4):549-56. PMID: 2104640.
    View in: PubMed
  449. Everitt DE, Avorn J. Systemic effects of medications used to treat glaucoma. Ann Intern Med. 1990 Jan 15; 112(2):120-5. PMID: 1967209.
    View in: PubMed
  450. Soumerai SB, McLaughlin TJ, Avorn J. Quality assurance for drug prescribing. Qual Assur Health Care. 1990; 2(1):37-58. PMID: 2103870.
    View in: PubMed
  451. Gurwitz JH, Avorn J. Old age--is it a risk for adverse drug reactions? Agents Actions Suppl. 1990; 29:13-25. PMID: 2180261.
    View in: PubMed
  452. Avorn J. The elderly and drug policy: coming of age. Health Aff (Millwood). 1990; 9(3):6-19. PMID: 2121636.
    View in: PubMed
  453. Buchwald D, Soumerai SB, VanDevanter N, Wessels MR, Avorn J. Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome. Rev Infect Dis. 1989 Jul-Aug; 11(4):619-24. PMID: 2772467.
    View in: PubMed
  454. Avorn J, Dreyer P, Connelly K, Soumerai SB. Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study. N Engl J Med. 1989 Jan 26; 320(4):227-32. PMID: 2911307.
    View in: PubMed
  455. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989; 42(10):937-45. PMID: 2681546.
    View in: PubMed
  456. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med. 1989; 28(6):577-82. PMID: 2648605.
    View in: PubMed
  457. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q. 1989; 67(2):268-317. PMID: 2698446.
    View in: PubMed
  458. Beers M, Avorn J, Soumerai SB, Everitt DE, Sherman DS, Salem S. Psychoactive medication use in intermediate-care facility residents. JAMA. 1988 Nov 25; 260(20):3016-20. PMID: 2903260.
    View in: PubMed
  459. Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med. 1988 Aug; 148(8):1720-4. PMID: 3401094.
    View in: PubMed
  460. Cleary PD, Singer E, Rogers TF, Avorn J, Van Devanter N, Soumerai S, Perry S, Pindyck J. Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. Am J Public Health. 1988 Aug; 78(8):953-7. PMID: 3389433; PMCID: PMC1349859.
  461. Avorn J. Pharmacology and geriatric practice: a case study in technology nontransfer. Clin Pharmacol Ther. 1987 Dec; 42(6):674-6. PMID: 3690946.
    View in: PubMed
  462. Soumerai SB, Avorn J, Gortmaker S, Hawley S. Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. Am J Public Health. 1987 Dec; 77(12):1518-23. PMID: 3674250; PMCID: PMC1647178.
  463. Sherman DS, Avorn J, Campion EW. Cimetidine use in nursing homes: prolonged therapy and excessive doses. J Am Geriatr Soc. 1987 Nov; 35(11):1023-7. PMID: 3668138.
    View in: PubMed
  464. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med. 1987 Aug 27; 317(9):550-6. PMID: 3302713.
    View in: PubMed
  465. Campion EW, Avorn J, Reder VA, Olins NJ. Overmedication of the low-weight elderly. Arch Intern Med. 1987 May; 147(5):945-7. PMID: 3579447.
    View in: PubMed
  466. Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G. Information and education as determinants of antibiotic use: report of Task Force 5. Rev Infect Dis. 1987 May-Jun; 9 Suppl 3:S286-96. PMID: 3299648.
    View in: PubMed
  467. Pindyck J, Avorn J, Kuriyan M, Reed M, Iqbal MJ, Levine SJ. Blood donation by the elderly. Clinical and policy considerations. JAMA. 1987 Mar 06; 257(9):1186-8. PMID: 3806916.
    View in: PubMed
  468. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Med Care. 1987 Mar; 25(3):210-21. PMID: 3821226.
    View in: PubMed
  469. Soumerai SB, Avorn J. Changing prescribing practices through individual continuing education. JAMA. 1987 Jan 23-30; 257(4):487. PMID: 3795431.
    View in: PubMed
  470. Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med. 1986 Dec; 146(12):2393-6. PMID: 3778076.
    View in: PubMed
  471. Avorn J, Niessen LC. Relationship between long bone fractures and water fluoridation. Gerodontics. 1986 Oct; 2(5):175-9. PMID: 3468035.
    View in: PubMed
  472. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug "detailing". Med Care. 1986 Apr; 24(4):313-31. PMID: 3083161.
    View in: PubMed
  473. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986 Jan 17; 255(3):357-60. PMID: 2867235.
    View in: PubMed
  474. Avorn J. Drug innovation and public policy: some speculations. Health Aff (Millwood). 1986; 5(2):121-7. PMID: 3744273.
    View in: PubMed
  475. Avorn JL. Medicine, health, and the geriatric transformation. Daedalus. 1986; 211-25. PMID: 10275800.
    View in: PubMed
  476. Cleary PD, Rogers TF, Singer E, Avorn J, van Devanter N, Perry S, Pindyck J. Health education about AIDS among seropositive blood donors. Health Educ Q. 1986; 13(4):317-29. PMID: 3023260.
    View in: PubMed
  477. Soumerai SB, Avorn J. Physician education and cost containment. JAMA. 1985 Apr 05; 253(13):1876-7. PMID: 3974070.
    View in: PubMed
  478. Avorn J. Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med. 1984 May 17; 310(20):1294-301. PMID: 6425686.
    View in: PubMed
  479. Avorn J. Drug revolution places prescribing practices in question. Bus Health. 1984 Mar; 1(4):35-9. PMID: 10264952.
    View in: PubMed
  480. Soumerai SB, Avorn J. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions. Milbank Mem Fund Q Health Soc. 1984; 62(3):447-74. PMID: 6433223.
    View in: PubMed
  481. Avorn J, Soumerai SB. A new approach to reducing suboptimal drug use. JAMA. 1983 Oct 07; 250(13):1752-3. PMID: 6411945.
    View in: PubMed
  482. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 1983 Jun 16; 308(24):1457-63. PMID: 6406886.
    View in: PubMed
  483. Soumerai SB, Avorn J. Perceived health, life satisfaction, and activity in urban elderly: a controlled study of the impact of part-time work. J Gerontol. 1983 May; 38(3):356-62. PMID: 6841933.
    View in: PubMed
  484. Avorn J. Biomedical and social determinants of cognitive impairment in the elderly. J Am Geriatr Soc. 1983 Mar; 31(3):137-43. PMID: 6338092.
    View in: PubMed
  485. Avorn J. Drug policy in the aging society. Health Aff (Millwood). 1983; 2(3):23-32. PMID: 6654312.
    View in: PubMed
  486. Avorn J, Soumerai SB. Use of a computer-based Medicaid drug data to analyze and correct inappropriate medication use. J Med Syst. 1982 Aug; 6(4):377-86. PMID: 6754838.
    View in: PubMed
  487. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982 Jul; 73(1):4-8. PMID: 7091173.
    View in: PubMed
  488. Avorn J. Ethics and experts. 2. A physician's perspective. Hastings Cent Rep. 1982 Jun; 12(3):11-2. PMID: 7107231.
    View in: PubMed
  489. Avorn J, Langer E. Induced disability in nursing home patients: a controlled trial. J Am Geriatr Soc. 1982 Jun; 30(6):397-400. PMID: 7077022.
    View in: PubMed
  490. Avorn J. Nursing-home infections - the context. N Engl J Med. 1981 Sep 24; 305(13):759-60. PMID: 6790993.
    View in: PubMed
  491. Lieff J, Avorn J, Caddell H, Anderson H, Gorlin P, Kennedy S, Goodwin J, Verlenden L. Attitudes of the medical profession toward drug abuse. Am J Public Health. 1973 Dec; 63(12):1035-9. PMID: 4759868; PMCID: PMC1775356.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu.
Avorn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_